Tricuspid valve regurgitation
Conditions
Interventions
None listed
Sponsors
Kusunose Kenya
Eligibility
Inclusion criteria
Inclusion criteria: Cases diagnosed with Severe TR who underwent transthoracic echocardiography (TTE) at the University of the Ryukyus, Okinawa Prefectural Chubu Hospital, or Naha City Hospital between January 1, 2014, and December 31, 2023 (Mild/Moderate TR Group) Cases diagnosed with Mild or Moderate TR who underwent transthoracic echocardiography (TTE) two or more times at the University of the Ryukyus, Okinawa Prefectural Chubu Hospital, or Naha City Hospital between January 1, 2014, and December 31, 2023
Exclusion criteria
Exclusion criteria: (Severe TR Group) 1. Echocardiographic images are not suitable for AI analysis. 2. Age at the time of the first TTE was under 18 years. (Mild/Moderate TR Group) 1. Echocardiographic images are not suitable for AI analysis. 2. Age at the time of the first TTE was under 18 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Composite endpoint consisting of all-cause mortality and hospitalization for heart failure occurring at 30 days, 1 year, and during annual follow-up periods stratified by TR severity. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Clinical Events Clinical events at 30 days, 1 year, and annually thereafter All-cause mortality (cardiovascular and non-cardiovascular death) All hospitalizations (heart failure, cardiovascular, and non-cardiovascular hospitalizations) Myocardial infarction Stroke Initiation of renal replacement therapy Bleeding Surgical/catheter-based interventions New pacemaker implantation 2. Echocardiography Parameters 3.Validation of the accuracy of ultrasound image analysis software Us2.ai | — |
Contacts
Public ContactKenya Kusunose
University of the Ryukyus Graduate School
Outcome results
None listed